Navigation Links
Brain scientists extend map of fear memory formation
Date:1/27/2010

Draw a map of the brain when fear and anxiety are involved, and the amygdalathe brain's almond-shaped center for panic and fight-or-flight responseslooms large.

But the amygdala doesn't do its job alone. Scientists at Emory University have recently built upon work from others, extending the fear map to part of the brain known as the prelimbic cortex.

Researchers led by Kerry Ressler, MD, PhD, found that mice lacking a critical growth factor in the prelimbic cortex have trouble remembering to fear electric shocks. The discovery could help improve diagnosis and treatment for anxiety disorders such as post-traumatic stress disorder and phobias.

The results are published online this week in the Proceedings of the National Academy of Sciences. Ressler is a researcher at Emory University's Yerkes National Primate Research Center, an associate professor of psychiatry and behavioral sciences at Emory University School of Medicine and a member of the Atlanta-based Center for Behavioral Neuroscience. He is the first practicing psychiatrist to be appointed a Howard Hughes Medical Investigator. The research was conducted in mice at the Yerkes Research Center.

Scientists describe the molecule BDNF (brain-derived neurotrophic factor) as Miracle-Gro for brain cells. It's a protein that pushes brain cells to withstand stress and make new connections. In other parts of the brain such as the amygdala, interfering with BDNF's effects blocks the acquisition of fear memory.

Some variations in the human gene for BDNF are thought to increase the risk for anxiety disorders and even change the anatomy of the prefrontal cortex in affected individuals.

"The prelimbic cortex is part of the medial prefrontal cortex, which appears to be important for emotional regulation in rodents as well as humans," Ressler says. "Evidence is building that these regions may be dysregulated or even over-active in fear and anxiety disorders in humans.

Working with Ressler, postdoctoral associate Dennis Choi and colleagues took advantage of a strain of genetically engineered mice that lack the BDNF gene in certain parts of the brain. These include the prelimbic cortex but exclude the amygdala and other regions such as the hippocampus.

If mice are electrically shocked just after they hear a certain tone, they gradually learn to fear that tone, and they show that fear by freezing. The BDNF-altered mice could run around and respond to shocks just as well, and could still learn to fear tones "in the moment."

However, they seemed to have trouble retaining fear memories as time passed. After learning to fear the tone, the altered mice didn't freeze as much, compared to normal mice, one hour or a day later. Using a different approach, the researchers also found that mice injected with a virus that eliminates the BDNF gene in the prelimbic cortex display similar characteristics.

"This work is important for extending our understanding of how BDNF is important for neuronal plasticity, learning and memory," Ressler says. "Together with our previous work, these data suggest that preventing neural plasticity in very precise, but critical brain regions, can have vastly different effects on emotional memory.

"It is becoming increasingly clear that these prefrontal cortex regions are functionally associated with regions of the brain known for a long time to be involved in emotion, such as the amygdala and hippocampus," he adds. "Understanding the molecular and cellular mechanisms of these connections in rodent models will provide scientists a better understanding of how these similar areas are functioning in humans."

A related paper in PNAS from Keqiang Ye, PhD, associate professor of pathology and laboratory medicine at Emory, and colleagues describes a family of compounds that can mimic BDNF.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Clinical depression linked to abnormal emotional brain circuits
4. Brain imaging reveals breakdown of normal emotional processing
5. Brain cells work differently than previously thought
6. Vaccine Stops Alzheimers Brain Tangles
7. Research may unlock mystery of autisms origin in the brain
8. Scientists Spot Brains Free Will Center
9. Free will takes flight: how our brains respond to an approaching menace
10. Alcoholics With Cirrhosis Have More Brain Damage
11. Brain Lesions Predict MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... The University of Western States (UWS) ... 2016 National SACA Leadership Conference on the Portland campus September 23-25. The conference ... come together and develop skills to be future leaders in the profession. ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... has found that more than 40 percent of participating fifth-grade students already have ... of Allergy and Asthma Clinical Research in the Division of Pulmonary, Allergy and ...
(Date:5/5/2016)... ... 2016 , ... In order to increase comfort, convenience and ... Seattle-based steam bath and sauna manufacturer recently launched amerecConnect™ , a new ... app, developed for both smartphones and personal computers perfectly emulates that of the ...
(Date:5/5/2016)... ... 2016 , ... United Collection Bureau, Inc. (UCB) announces Sarah Clark as its ... of experience within the healthcare revenue cycle industry. With a primary focus of end-to-end ... Financial Services at Spectrum Health. While at Spectrum Health, Clark helped Spectrum achieve the ...
(Date:5/5/2016)... ... May 05, 2016 , ... CURE Media Group ... today announced a new collaboration with Imerman Angels to expand outreach and ... the world. , “Imerman Angels provides an emotional lifeline to patients and families facing ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: